Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease | Zendy

Qian You | Zendy; Qing Peng | Zendy; Zemou Yu | Zendy; Haiqiang Jin | Zendy; Jing Zhang | Zendy; Wei Sun | Zendy; Yining Huang | Zendy

Open Access

Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease

Author(s) -

Qian You,

Qing Peng,

Zemou Yu,

Haiqiang Jin,

Jing Zhang,

Wei Sun,

Yining Huang

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20201519

Subject(s) - sphingolipid , ceramide , sphingomyelin , pathogenesis , disease , fabry disease , medicine , coronary artery disease , glycosphingolipid , cardiology , gastroenterology , pathology , biology , cholesterol , biochemistry , apoptosis

Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there're few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research